| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 2.117.784.504 $ | +182.276.650 $ | +4,2 % | 6 | 1.935.507.854 $ | +229.838.301 $ | +19,2 % | 6 | 1.791.467.184 $ | +516.331.960 $ | +68,8 % | 9 | ||||
| Arcellx, Inc. | ACLX | → 0 | 771.682.600 $ | +333.486.244 $ | +76,1 % | 1 | 438.196.356 $ | -113.581.570 $ | -20,6 % | 1 | 551.777.926 $ | +109.213.048 $ | +24,7 % | 1 | |
| Arcus Biosciences, Inc. | RCUS | → 0 | Schwach | 678.774.816 $ | -70.077.215 $ | -9,4 % | 1 | 748.852.031 $ | +321.475.295 $ | +75,2 % | 1 | 427.376.736 $ | +171.579.190 $ | +67,1 % | 1 |
| Lakefront Biotherapeutics NV | GLPG | → 0 | 501.224.310 $ | -49.391.980 $ | -9,0 % | 1 | 550.616.290 $ | -28.130.713 $ | -4,9 % | 1 | 578.747.003 $ | +111.104.722 $ | +23,8 % | 1 | |
| ASSEMBLY BIOSCIENCES, INC. | ASMB | → 0 | Schwach | 125.024.600 $ | -28.203.748 $ | -18,4 % | 1 | 153.228.348 $ | +37.890.338 $ | +32,9 % | 1 | 115.338.010 $ | +75.302.395 $ | +188,1 % | 1 |
| Merus N.V. | → 0 | 42.605.417 $ | +18.802.497 $ | +79,0 % | 1 | ||||||||||
| Tango Therapeutics, Inc. | TNGX | → 0 | Neutral | 40.777.321 $ | +15.922.573 $ | +64,1 % | 1 | ||||||||
| Kyverna Therapeutics, Inc. | KYTX | → 0 | Schwach | 35.608.407 $ | -3.177.112 $ | -8,2 % | 1 | 38.785.519 $ | +14.028.805 $ | +56,7 % | 1 | 24.756.714 $ | +12.089.529 $ | +95,4 % | 1 |
| Xilio Therapeutics, Inc. | XLO | → 0 | Stark | 5.469.771 $ | -359.539 $ | -6,2 % | 1 | 5.829.310 $ | -1.843.854 $ | -24,0 % | 1 | 7.673.164 $ | +1.482.368 $ | +23,9 % | 1 |
| CYPHERPUNK TECHNOLOGIES INC. | CYPH | → 0 | Neutral | 2.414.893 $ | +835.638 $ | +52,9 % | 1 | ||||||||
| 2.117.784.504 $ | +182.276.650 $ | +4,2 % | 6 | 1.935.507.854 $ | +229.838.301 $ | +19,2 % | 6 | 1.791.467.184 $ | +516.331.960 $ | +68,8 % | 9 | ||||